posted on 2025-01-29, 13:18authored byMatthew Badland, Maria S. Brown, Nessa Carson, Douglas J. Critcher, Steven J. Fussell, Michael Hawksworth, Heather Ingram, Rebecca A. Johnson, Rajesh Kumar, Jinu S. Mathew, Laura McGivern, Philip Peach, Ben Pibworth, Alexandru I. Pop, Emily K. Rose, Nathan J. Rutland, Adam Scott, Steven J. R. Twiddle
The compound (S)-oxetan-2-ylmethyl tosylate 1 was identified as a key synthetic fragment for the introduction
of the 2-substituted oxetane functionality in potential drug candidates
under development in our laboratories. The focus of this paper is
to highlight methodologies evaluated in our quest for synthetic routes
to 2-substituted oxetanes suitable for enabling manufacture. Of the
five routes investigated, three (Route 1A, Route 2, and Route 3) were
successfully demonstrated in the laboratory. Subsequently, Route 3
was executed at scale to deliver metric ton quantities of the oxetane
tosylate 1 as a solution in EtOAc, which was integrated
into the synthesis of 2 and aforementioned drug candidates.